Cite
MLA Citation
Frits van Rhee et al.. “Long-term safety of siltuximab in patients with idiopathic multicentric Castleman disease: a prespecified, open-label, extension analysis of two trials.” Lancet, vol. 7, no. 3, 2020, pp. e209–e217. http://access.bl.uk/ark:/81055/vdc_100101666602.0x00000b